Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation

PURPOSE: Graft-versus-host disease (GVHD) is an important complication after human leukocyte antigen (HLA) haploidentical donor (HID) hematopoietic stem cell transplantation (HSCT), which may lead to poor prognosis. Our study intends to identify the efficacy and safety of mesenchymal stem cells (MSC...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Meng-Zhu, Liu, Xin-Xin, Qiu, Zhi-Yuan, Xu, Lan-Ping, Zhang, Xiao-Hui, Wang, Yu, Yan, Chen-Hua, Chen, Huan, Chen, Yu-Hong, Han, Wei, Wang, Feng-Rong, Wang, Jing-Zhi, Liu, Si-Ning, Liu, Kai-Yan, Huang, Xiao-Jun, Mo, Xiao-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Reasearch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796067/
https://www.ncbi.nlm.nih.gov/pubmed/35096361
http://dx.doi.org/10.1177/20406207211072838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796067/
https://www.ncbi.nlm.nih.gov/pubmed/35096361
http://dx.doi.org/10.1177/20406207211072838

Ejemplares similares